Concepedia

Mariela Bettini

MB

8

Publications

961

Citations

8

H-Index

2011

Active since

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Hospital Italiano de Buenos Aires

Stanford University

International University of Health and Welfare

National Hospital Organization Hanamaki Hospital

Mariela Bettini is an author at Alexion Pharmaceuticals (United States) specializing in medicine, immunology, and autoimmune disease.

Top concepts

Publications per year

2011–2020

8

Publications

8

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

, , +3

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis

Gisella Gargiulo‐Monachelli, Franco Janota, Mariela Bettini et al. · European Journal of Neurology · 2012 · 50 citations · Full text

Incidence of Autoimmune Myasthenia Gravis in a Health Maintenance Organization in Buenos Aires, Argentina

Mariela Bettini, Marcelo Chaves, Edgardo Cristiano et al. · Neuroepidemiology · 2017 · 23 citations

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

Hiroyuki Murai, Akiyuki Uzawa, Yasushi Suzuki et al. · Journal of the Neurological Sciences · 2019 · 23 citations · Full text

Rows per page

1–5 of 8